Gilead Sciences, Inc (GILD) FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Q2 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q2 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Jacquie Ross — Senior Vice President of Treasury and Investor…
Gilead Sciences, Inc (GILD) Q3 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Jacquie Ross — Senior Vice President of Treasury and Investor…
AlphaGraphs
Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers
Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up 5% year-over-year. Net income attributable…
AlphaGraphs
Gilead Sciences (GILD) Earnings: 1Q23 Key Numbers
Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down 4% year-over-year. Net income attributable…
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q4 2022 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of 2022 when its revenues moved…
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its third-quarter 2021 earnings today after the closing bell. The revenue increased by 13% to $7.4 billion…
Gilead Sciences Inc (GILD) Q2 2021 Earnings Call Transcript
Gilead Sciences Inc (NASDAQ: GILD) Q2 2021 earnings call dated Jul. 29, 2021. Corporate Participants: Jacquie Ross — Investor Relations Daniel O’Day — Chairman And Chief…
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q2 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell. The revenue increased by 21% to $6.2 billion…
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q1 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell. The revenue increased by 16% to $6.4 billion…